bioAffinity Technologies, Inc. (BIAF) vs Evogene Ltd. (EVGN)
A side-by-side comparison of bioAffinity Technologies, Inc. and Evogene Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BIAF
bioAffinity Technologies, Inc.
$6.04HealthcareDelayed quote: Oct 6, 2026, 12:10 PM EDT
EVGN
Evogene Ltd.
$0.41HealthcareDelayed quote: Oct 6, 2026, 12:10 PM EDT
Total return — BIAF vs EVGN
growth of $100 · dividends reinvested · last 4yBIAF -99.8% (-79.8%/yr)EVGN -96.6% (-57.2%/yr)EVGN compounded faster over this window
Log scale — wide-divergence pair
BIAF EVGN
BIAF vs EVGN: by the numbers
- •EVGN is the larger company ($4M vs $3M market cap).
- •Both run net losses; BIAF's is the smaller (-257.33% vs -694.19% net margin).
Metrics side by side
Valuation
| Metric | BIAF | EVGN |
|---|---|---|
| P/S ratio | 0.43 | 2.68 |
| P/B ratio | 0.67 | N/A |
Profitability
| Metric | BIAF | EVGN |
|---|---|---|
| Gross margin | 23.21% | -6.25% |
| Operating margin | -171.58% | -364.24% |
| Net margin | -257.33% | -694.19% |
| ROE | -402.92% | N/A |
| ROIC | -237.93% | -130.12% |
Growth (annualized)
| Metric | BIAF | EVGN |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 2.86% |
| Total return CAGR (5Y) | N/A | -56.46% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.